Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant

US6096313A · kind A · utility

Assignee

• LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

• Elke Jager · Frankfurt am Main, DE
• Alexander Knuth · Frankfurt am Main, DE

Key dates

• Filing date: Feb 9, 1996
• Grant date: Aug 1, 2000
• Expiry date: Feb 9, 2016

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S435/975
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Granulocyte-macrophage colony stimulating factor ("GM-CSF") has been found to act as an adjuvant when administered to subjects. Compositions of GM-CSF and immunogenic compositions are presented, as is the use of GM-CSF alone and in these compositions.